Inotiv, Inc. (NOTVQ)

OTCMKTS · Delayed Price · Currency is USD

0.0200

-0.0160 (-44.44%)

At close: Jun 16, 2026

-99.10% (1Y)

Market Cap	697.76K -99.2%
Revenue (ttm)	507.36M +5.6%
Net Income	-86.97M
EPS	-2.53
Shares Out	34.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,671,036
Open	0.0382
Previous Close	0.0360
Day's Range	0.0200 - 0.0382
52-Week Range	0.0200 - 2.4400
Beta	3.77
Analysts	Strong Buy
Price Target	5.00 (+24,900.0%)
Earnings Date	n/a

About Inotiv

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the ... [Read more]

Industry Commercial Physical and Biological Research

Founded 1974

Employees 2,046

Stock Exchange OTCMKTS

Ticker Symbol NOTVQ

Full Company Profile

Financial Performance

In fiscal year 2025, Inotiv's revenue was $513.02 million, an increase of 4.54% compared to the previous year's $490.74 million. Losses were -$68.63 million, -36.72% less than in 2024.

Financial Statements